Study reviews the status of microbial succinic acid production

FHS
June 30, 2023
4:12 am

The current status and future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the peer-reviewed journal Industrial Biotechnology.

Drug development was once a marathon. New tools and timelines are turning it into a sprint

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more

March 22, 2024

Inside the telehealth-fueled GLP-1 alternative market

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These medications have made

November 26, 2024

Prabotulinumtoxin A biosimilar by AEON Biopharma for Spasmodic Torticollis (Cervical Dystonia): Likelihood of Approval

Prabotulinumtoxin A biosimilar is under clinical development by AEON Biopharma and currently in Phase II for Spasmodic Torticollis (Cervical Dystonia).

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.